| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.009 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |